Long-term use of proton pump inhibitors among community-dwelling persons with and without Alzheimer’s disease

Long-term use of proton pump inhibitors among community-dwelling persons with and without... Eur J Clin Pharmacol (2017) 73:1149–1158 DOI 10.1007/s00228-017-2273-8 PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Long-term use of proton pump inhibitors among community-dwelling persons with and without Alzheimer’s disease 1,2 1,2,3 3,4 1,2 Heidi Juntunen & Heidi Taipale & Antti Tanskanen & Anna-Maija Tolppanen & 3,4 1,2 1,2 Jari Tiihonen & Sirpa Hartikainen & Miia Tiihonen Received: 6 April 2017 /Accepted: 24 May 2017 /Published online: 2 June 2017 Springer-Verlag Berlin Heidelberg 2017 Abstract among persons with than without AD (20.3 and 17.9%, re- Purpose The aim of this study is to determine the prevalence spectively, p < 0.001). Factors related to long-term use of PPIs of use and long-term use (≥180 days) of proton pump inhib- were female sex, history of gastrointestinal bleedings, AD, itors (PPIs) and associated factors among community- rheumatoid arthritis, cardiovascular disease, asthma/COPD dwellers with and without Alzheimer’s disease (AD). and use of bisphosphonates, SSRIs and antithrombotic agents. Methods MEDALZ cohort encompassed all persons who re- Median follow-up time was 2.6 years among persons with AD ceived a verified diagnosis of AD in Finland during the years and 3.5 years among persons without AD. Median duration of 2005–2011 and their age-, sex-, and region of residence- the first long-term http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Clinical Pharmacology Springer Journals

Long-term use of proton pump inhibitors among community-dwelling persons with and without Alzheimer’s disease

Loading next page...
 
/lp/springer_journal/long-term-use-of-proton-pump-inhibitors-among-community-dwelling-1GIi60tiHG
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Biomedicine; Pharmacology/Toxicology
ISSN
0031-6970
eISSN
1432-1041
D.O.I.
10.1007/s00228-017-2273-8
Publisher site
See Article on Publisher Site

Abstract

Eur J Clin Pharmacol (2017) 73:1149–1158 DOI 10.1007/s00228-017-2273-8 PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Long-term use of proton pump inhibitors among community-dwelling persons with and without Alzheimer’s disease 1,2 1,2,3 3,4 1,2 Heidi Juntunen & Heidi Taipale & Antti Tanskanen & Anna-Maija Tolppanen & 3,4 1,2 1,2 Jari Tiihonen & Sirpa Hartikainen & Miia Tiihonen Received: 6 April 2017 /Accepted: 24 May 2017 /Published online: 2 June 2017 Springer-Verlag Berlin Heidelberg 2017 Abstract among persons with than without AD (20.3 and 17.9%, re- Purpose The aim of this study is to determine the prevalence spectively, p < 0.001). Factors related to long-term use of PPIs of use and long-term use (≥180 days) of proton pump inhib- were female sex, history of gastrointestinal bleedings, AD, itors (PPIs) and associated factors among community- rheumatoid arthritis, cardiovascular disease, asthma/COPD dwellers with and without Alzheimer’s disease (AD). and use of bisphosphonates, SSRIs and antithrombotic agents. Methods MEDALZ cohort encompassed all persons who re- Median follow-up time was 2.6 years among persons with AD ceived a verified diagnosis of AD in Finland during the years and 3.5 years among persons without AD. Median duration of 2005–2011 and their age-, sex-, and region of residence- the first long-term

Journal

European Journal of Clinical PharmacologySpringer Journals

Published: Jun 2, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off